Loading...

ViewRay, Inc.

6L9.FXETRA
Healthcare
Medical - Devices
0.03
0.02(2400.00%)
German Market opens in 14h 20m

ViewRay, Inc. Fundamental Analysis

ViewRay, Inc. (6L9.F) shows weak financial fundamentals with a PE ratio of -0.05, profit margin of -1.05%, and ROE of -85.17%. The company generates $4.7B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position3009.68%
PEG Ratio-0.01
Current Ratio2.36

Areas of Concern

ROE-85.17%
Operating Margin-1.05%
We analyze 6L9.F's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -181.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-181.5/100

We analyze 6L9.F's fundamental strength across five key dimensions:

Efficiency Score

Weak

6L9.F struggles to generate sufficient returns from assets.

ROA > 10%
-39.55%

Valuation Score

Excellent

6L9.F trades at attractive valuation levels.

PE < 25
-0.05
PEG Ratio < 2
-0.01

Growth Score

Weak

6L9.F faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

6L9.F shows balanced financial health with some risks.

Debt/Equity < 1
1.05
Current Ratio > 1
2.36

Profitability Score

Weak

6L9.F struggles to sustain strong margins.

ROE > 15%
-8517.00%
Net Margin ≥ 15%
-1.05%
Positive Free Cash Flow
No

Key Financial Metrics

Is 6L9.F Expensive or Cheap?

P/E Ratio

6L9.F trades at -0.05 times earnings. This suggests potential undervaluation.

-0.05

PEG Ratio

When adjusting for growth, 6L9.F's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values ViewRay, Inc. at 0.06 times its book value. This may indicate undervaluation.

0.06

EV/EBITDA

Enterprise value stands at -3.05 times EBITDA. This is generally considered low.

-3.05

How Well Does 6L9.F Make Money?

Net Profit Margin

For every $100 in sales, ViewRay, Inc. keeps $-1.05 as profit after all expenses.

-1.05%

Operating Margin

Core operations generate -1.05 in profit for every $100 in revenue, before interest and taxes.

-1.05%

ROE

Management delivers $-85.17 in profit for every $100 of shareholder equity.

-85.17%

ROA

ViewRay, Inc. generates $-39.55 in profit for every $100 in assets, demonstrating efficient asset deployment.

-39.55%

Following the Money - Real Cash Generation

Operating Cash Flow

ViewRay, Inc. generates limited operating cash flow of $-4.21B, signaling weaker underlying cash strength.

$-4.21B

Free Cash Flow

ViewRay, Inc. generates weak or negative free cash flow of $-4.39B, restricting financial flexibility.

$-4.39B

FCF Per Share

Each share generates $-0.53 in free cash annually.

$-0.53

FCF Yield

6L9.F converts -39.44% of its market value into free cash.

-39.44%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.05

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.06

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.37

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.36

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.85

vs 25 benchmark

ROA

Return on assets percentage

-0.40

vs 25 benchmark

ROCE

Return on capital employed

-0.61

vs 25 benchmark

How 6L9.F Stacks Against Its Sector Peers

Metric6L9.F ValueSector AveragePerformance
P/E Ratio-0.0529.88 Better (Cheaper)
ROE-85.17%682.00% Weak
Net Margin-105.01%-46037.00% (disorted) Weak
Debt/Equity1.050.42 Weak (High Leverage)
Current Ratio2.364.49 Strong Liquidity
ROA-39.55%-16420.00% (disorted) Weak

6L9.F outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews ViewRay, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ